Semerjian Harout — SEC insider filings

SEC reporting owner CIK 1809747. 6 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2022-01-25 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
GERON CORP (GERN)President & CEO, Director21 leg · 53,500 sh · $50,825—2
GLYCOMIMETICS INC (GLYC)Chief Executive Officer, Director41 leg · 25,000 sh · $32,250—3

Insider filings — Semerjian Harout

FiledFormIssuerReported transactionsSource
2026-11-164GERON CORP (GERN)Purchase (P): 53,500 @ $0.95EDGAR
2025-08-084GERON CORP (GERN)Grant/award (A): 7,000,000 (derivative) @ $0 · Grant/award (A): 4,000,000 (derivative) @ $0EDGAR
2024-01-174GLYCOMIMETICS INC (GLYC)Grant/award (A): 695,000 (derivative) @ $0EDGAR
2023-01-204GLYCOMIMETICS INC (GLYC)Grant/award (A): 651,200 (derivative) @ $0EDGAR
2022-11-144GLYCOMIMETICS INC (GLYC)Purchase (P): 25,000 @ $1.29EDGAR
2022-01-254GLYCOMIMETICS INC (GLYC)Grant/award (A): 423,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1809747 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs